0001761468-22-000001.txt : 20220210 0001761468-22-000001.hdr.sgml : 20220210 20220210133529 ACCESSION NUMBER: 0001761468-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220210 DATE AS OF CHANGE: 20220210 EFFECTIVENESS DATE: 20220210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cytonus Therapeutics, Inc. CENTRAL INDEX KEY: 0001761468 IRS NUMBER: 811664855 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-433094 FILM NUMBER: 22612879 BUSINESS ADDRESS: STREET 1: 111 E. DESHLER AVE. CITY: COLUMBUS STATE: OH ZIP: 43206 BUSINESS PHONE: 631-258-4070 MAIL ADDRESS: STREET 1: 111 E. DESHLER AVE. CITY: COLUMBUS STATE: OH ZIP: 43206 D 1 primary_doc.xml X0708 D LIVE 0001761468 Cytonus Therapeutics, Inc. 111 E. DESHLER AVE. COLUMBUS OH OHIO 43206 631-258-4070 DELAWARE None None Corporation true 2018 Remo Moomiaie 111 E Deshler Avenue Columbus OH OHIO 43206 Executive Officer Director Christopher Thorne 111 E Deshler Avenue Columbus OH OHIO 43206 Director Richard Klemke 111 E Deshler Avenue Columbus OH OHIO 43206 Director Manisha Narasimhan 111 E Deshler Avenue Columbus OH OHIO 43206 Director Biotechnology Decline to Disclose 06b false 2022-01-29 false true true false 0 1000000 15000 985000 false 1 0 0 0 false Cytonus Therapeutics, Inc. /s/ Remo Moomiaie Remo Moomiaie President 2022-02-10